03 February 2016
(Journal 6611)
| | | SPC/GB13/018 | Supplementary Protection Certificates | Supplementary Protection Certificate No SPC/GB13/018 filed by Pfizer Inc. in respect of the product “Crizotinib, optionally in the form of a pharmaceutically acceptable salt, hydrate or solvate thereof”, the filing of which was advertised in journal No 6465 dated 17/04/2013 has had the date of the marketing authorisation corrected to 26/10/2012. |